见解资源

医学科学界一直在寻找更好的方法将药物送入体内，并使药物的治疗效果最大化。近年来，脂质体技术在药物输送领域发挥了重要作用，目前市场上已有多种产品可供使用，且还有更多的剂型正在进行临床试验评估。

作为辉瑞内部的全球化合同开发和制造组织（CDMO），辉瑞CentreOne可生产定制的API、无菌注射剂灌封和高效口服固体制剂。 40多年以来，辉瑞CentreOne为其生物制药合作伙伴生产过各种复杂的药物，指引其完成从药物开发到商业化的整个流程。Contract Pharma与辉瑞CentreOne总经理JoyL Silva通过交谈探讨了Embedded CDMO模式的优势、小分子制剂的总体趋势以及辉瑞CentreOne对未来增长的计划和预测。 点击此处阅读全文。

从CAR-T疗法和人工智能（AI）到《药品供应链安全法案》（DSCSA）的颁布，制药行业在过去五年发生了颠覆性的变革。随着药物开发创新不断趋向于为小范围的患者群体提供更加复杂、更具针对性的疗法，制造难题也随之出现，并且需要技术先进的解决方案来满足这一需求。 合同制药媒体与辉瑞CentreOne总经理JoyL Silva及其他行业领导者举行了一场座谈，研究企业经营如何发展以满足不断变化的行业需求，并探讨了我们对制药行业和外包的未来可以抱有什么样的期待。 点击此处阅读全文。

50多年来，辉瑞CentreOne一直是领先的特种API供应商。我们凭借质量、诚信、技术专长和供应保证，力求不断改进您的产品。我们制造特定领域的复杂化合物；皮质类固醇和激素类固醇、前列腺素和抗生素。但如果您需要放大和生产专有分子，则可选择定制API合同制造，这也是我们的核心竞争力之一。

A range of new treatment and administration routes are being introduced to pharma’s pipeline, bringing new complexities and prompting demand for experienced CDMOs. The pipeline’s trajectory is requiring new clinical manufacturing infrastructures and the need to find and engage contract partners w...

Contract developers and manufacturers of active pharmaceutical ingredients (APIs) are now playing an even more fundamental role in contemporary drug development strategies. A 2018 report by analyst firm visiongain forecasts that the overallpharmaceutical contract manufacturing market is growing f...

It has been extremely gratifying for everyone here in Kalamazoo, Michigan to have been in pharma’s corner in 2020, helping the industry from behind the scenes, manufacturing and delivering supplies of critical treatments. I am extremely proud to be a part of Pfizer CentreOne’s central role helping m...

战略合作伙伴应始终尝试不同的方式来创新并改善您的化合物或产品的价值，并要保持合作伙伴的热忱和激情，而非仅仅以供应商身份投入其中。随着合同服务和大量供应商重要性的日益提高，作出正确的选择比以往任何时候都更为重要。从何处着手？辉瑞CentreOne的合同制造主管Tom Wilson向大家分享了他在挑选完美的API合作伙伴方面的技巧。 点击此处阅读文章。

What’s the recipe for API project success? As established pharmaceutical companies continue to reduce manufacturing footprints to match their capital plans and small- to mid-size innovators pursue faster go-to-market models via virtual company routes, outsourcing managers are seeking better alliance...

We’re engaging our customers more meaningfully than ever and the results of this intelligent collaboration approach are showing. For the fifth consecutive year, Pfizer CentreOne has been selected as a winner of six 2021 CMO Leadership Awards presented by Outsourced Pharma and Life Science Leader....

As oral solid dose (OSD) drugs in development become more potent, regulatory expectations keep changing. To sustain compliance proactively, drug developers and their partners must develop a clear understanding to navigate current complex regulatory environments and build their manufacturing strategi...

The growth of the contract manufacturing sector can be attributed to a number of factors, particularly the increasing popularity of outsourcing as a manufacturing option. Outsourcing allows drug developers to access expertise and capabilities they may not possess in-house, as well as generating time...